Episode Details
Back to Episodes
Daily Roundup | Heidi Overton FDA Pick: What It Means for Approvals
Published 4 weeks, 2 days ago
Description
Trump names Heidi Overton to lead the FDA — and a Republican senator calls part of her record almost disqualifying on day one. We break down the confirmation fight, the regulatory risk to mRNA programs in oncology and immunology, Regeneron's Pasatru (garetosmab) approval for the ultra-rare bone disease fibrodysplasia ossificans progressiva, SK Biopharmaceuticals' Xcopri (cenobamate) patent settlement with MSN Laboratories, and SK Pharmteco's new high-potency API and ADC payload plants in Swords, Ireland. Visit us at thepharmacloseout.com.